IFRX
Price
$2.06
Change
+$0.01 (+0.49%)
Updated
Jul 13 closing price
Capitalization
303.42M
23 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$7.15
Change
-$0.22 (-2.99%)
Updated
Jul 13 closing price
Capitalization
441.53M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IFRX vs SGMT

IFRX vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
IFRX vs. SGMT commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Hold and SGMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (IFRX: $2.06 vs. SGMT: $7.15)
Brand notoriety: IFRX and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 69% vs. SGMT: 56%
Market capitalization -- IFRX: $303.42M vs. SGMT: $441.53M
IFRX [@Biotechnology] is valued at $303.42M. SGMT’s [@Biotechnology] market capitalization is $441.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 6 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • IFRX’s TA Score: 6 bullish, 4 bearish.
  • SGMT’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, IFRX is a better buy in the short-term than SGMT.

Price Growth

IFRX (@Biotechnology) experienced а -2.37% price change this week, while SGMT (@Biotechnology) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

IFRX is expected to report earnings on Aug 06, 2026.

SGMT is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($442M) has a higher market cap than IFRX($303M). IFRX YTD gains are higher at: 103.960 vs. SGMT (20.777). IFRX has higher annual earnings (EBITDA): -42.46M vs. SGMT (-48.74M). SGMT has more cash in the bank: 105M vs. IFRX (39.8M). SGMT has less debt than IFRX: SGMT (39K) vs IFRX (823K). IFRX has higher revenues than SGMT: IFRX (29.3K) vs SGMT (0).
IFRXSGMTIFRX / SGMT
Capitalization303M442M69%
EBITDA-42.46M-48.74M87%
Gain YTD103.96020.777500%
P/E RatioN/AN/A-
Revenue29.3K0-
Total Cash39.8M105M38%
Total Debt823K39K2,110%
FUNDAMENTALS RATINGS
IFRX: Fundamental Ratings
IFRX
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IFRXSGMT
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 22 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USPVX36.130.09
+0.25%
Union Street Partners Value A
AFDAX51.58N/A
N/A
American Century Large Cap Equity A
JGVRX45.63N/A
N/A
JPMorgan Growth Advantage R5
PXGAX28.45-0.20
-0.70%
Impax US Sustainable Economy A
PAXLX11.14-0.10
-0.89%
Impax Large Cap Fund Individual Investor

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and SGMT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+0.49%
SGMT - IFRX
32%
Poorly correlated
-2.99%
KURA - IFRX
32%
Poorly correlated
-4.72%
VIR - IFRX
31%
Poorly correlated
-2.41%
BMEA - IFRX
31%
Poorly correlated
+0.76%
VYGR - IFRX
31%
Poorly correlated
-5.81%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-2.99%
VIR - SGMT
41%
Loosely correlated
-2.41%
EDIT - SGMT
38%
Loosely correlated
-3.07%
INBX - SGMT
37%
Loosely correlated
-0.91%
GOSS - SGMT
37%
Loosely correlated
-15.09%
VKTX - SGMT
36%
Loosely correlated
-1.90%
More